ArticleArchives of Razi Institute2024
Effect of Three Insect Growth Regulators on The Avian Malaria Vector-Culiseta longiareolata Larvae- Field Population.
Article in Archives of Razi Institute, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A number of species within the Culicidae family are responsible for the transmission of pathogens to animals and humans. The study of these species and the fight against these natural enemies represent a significant area of concern for scientists in the present era. An inventory of Culicidae in the M'chouneche region (34° 56' 59.99" N, 6° 00' 0.00" E) (Biskra, southeastern Algeria) was conducted in various breeding sites between November 2022 and May 2023. Four species of Culicidae were identified: Culiseta longiareolata, Culex pipiens, Culex theileri, and Anopheles multicolor. To assess the efficacy of three insect growth regulators (Lufenuron, Teflubenzuron, and Spirotetramat) on the fourth larval stage of Cs. longiareolata, control tests were conducted under experimental conditions. Lufenuron demonstrated a markedly higher toxic effect, with a mortality rate of 57% (ranging from 0 to 100%), compared to Spirotetramat, which exhibited an average mortality rate of 37.71% (ranging from 0 to 80%), and Teflubenzuron, which showed an average mortality rate of 12.08% (ranging from 0 to 45%). The mortality rates demonstrated an increase from one concentration to the next over time. Furthermore, the correlation coefficient between the two factors (time and concentration) and the mortality rates was found to be low at 30%. Individuals that were treated after reaching the adult stage exhibited a notable delay in their development. For concentrations of 20 mg/L and 40 mg/L, the delay duration was approximately two days ± 12 hours. In contrast, the third concentration (80 mg/l) resulted in a development delay of approximately three days±15 hours.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.